496 related articles for article (PubMed ID: 21916970)
21. Cardiovascular health metrics defined by Life's Essential 8 scores and subsequent macrovascular and microvascular complications in individuals with type 2 diabetes: A prospective cohort study.
Huang ZG; Gao JW; Zhang HF; You S; Xiong ZC; Wu YB; Guo DC; Wang JF; Chen YX; Zhang SL; Liu PM
Diabetes Obes Metab; 2024 Jul; 26(7):2673-2683. PubMed ID: 38558498
[TBL] [Abstract][Full Text] [Related]
22. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
[TBL] [Abstract][Full Text] [Related]
23. Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes.
Kouidrat Y; Zaitouni A; Amad A; Diouf M; Desailloud R; Loas G; Lalau JD
J Diabetes Complications; 2017 Jan; 31(1):108-113. PubMed ID: 27847146
[TBL] [Abstract][Full Text] [Related]
24. Skin autofluorescence and complications of diabetes: does ethnic background or skin color matter?
Ahdi M; Gerdes VE; Graaff R; Kuipers S; Smit AJ; Meesters EW
Diabetes Technol Ther; 2015 Feb; 17(2):88-95. PubMed ID: 25562390
[TBL] [Abstract][Full Text] [Related]
25. Correlation between diabetic retinopathy severity and elevated skin autofluorescence as a marker of advanced glycation end-product accumulation in type 2 diabetic patients.
Hirano T; Iesato Y; Toriyama Y; Imai A; Chiba D; Murata T
J Diabetes Complications; 2014; 28(5):729-34. PubMed ID: 24795072
[TBL] [Abstract][Full Text] [Related]
26. Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.
Genuth S; Sun W; Cleary P; Gao X; Sell DR; Lachin J; ; Monnier VM
Diabetes; 2015 Jan; 64(1):266-78. PubMed ID: 25187362
[TBL] [Abstract][Full Text] [Related]
27. Skin AGEs and diabetic neuropathy.
Papachristou S; Pafili K; Papanas N
BMC Endocr Disord; 2021 Feb; 21(1):28. PubMed ID: 33622304
[TBL] [Abstract][Full Text] [Related]
28. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy.
Meerwaldt R; Links TP; Graaff R; Hoogenberg K; Lefrandt JD; Baynes JW; Gans RO; Smit AJ
Diabetologia; 2005 Aug; 48(8):1637-44. PubMed ID: 16021416
[TBL] [Abstract][Full Text] [Related]
29. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
Adamska A; Araszkiewicz A; Pilacinski S; Gandecka A; Grzelka A; Kowalska K; Malinska A; Nowicki M; Zozulinska-Ziolkiewicz D
Microvasc Res; 2019 Jan; 121():46-51. PubMed ID: 30312628
[TBL] [Abstract][Full Text] [Related]
30. Skin autofluorescence and peripheral neuropathy four years later in type 1 diabetes.
Rajaobelina K; Farges B; Nov S; Maury E; Cephise-Velayoudom FL; Gin H; Helmer C; Rigalleau V
Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27235334
[TBL] [Abstract][Full Text] [Related]
31. Rationale, study design and methodology of the LANDMARC trial: a 3-year, pan-India, prospective, longitudinal study to assess management and real-world outcomes of diabetes mellitus.
Das AK; Mithal A; Kumar KMP; Unnikrishnan AG; Kalra S; Thacker H; Sethi B; Ghosh R; Mathew A; Chodankar D; Mohanasundaram S; Menon SK; Trivedi C; Naqvi M; Kanade V; Salvi V; Chatterjee G; Rais N; Wangnoo SK; Chowdhury S; Zargar AH; Joshi S
Diabet Med; 2020 May; 37(5):885-892. PubMed ID: 31691356
[TBL] [Abstract][Full Text] [Related]
32. Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy.
Roos M; Oikonomou D; von Eynatten M; Luppa PB; Heemann U; Lutz J; Baumann M; Nawroth PP; Bierhaus A; Humpert PM
Cardiovasc Diabetol; 2010 Sep; 9():48. PubMed ID: 20822519
[TBL] [Abstract][Full Text] [Related]
33. Microvascular complications and prevalence of urgency incontinence in Japanese patients with type 2 diabetes mellitus: The dogo study.
Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Maruyama K; Ueda T; Senba H; Todo Y; Torisu M; Minami H; Onji M; Tanigawa T; Matsuura B; Hiasa Y; Miyake Y
Neurourol Urodyn; 2016 Nov; 35(8):1024-1027. PubMed ID: 26352009
[TBL] [Abstract][Full Text] [Related]
34. The association between skin autofluorescence and vascular complications in Chinese patients with diabetic foot ulcer: an observational study done in Shanghai.
Liu C; Xu L; Gao H; Ye J; Huang Y; Wu M; Xie T; Ni P; Yu X; Cao Y; Lu S
Int J Low Extrem Wounds; 2015 Mar; 14(1):28-36. PubMed ID: 25694437
[TBL] [Abstract][Full Text] [Related]
35. Higher skin autofluorescence in young people with Type 1 diabetes and microvascular complications.
Cho YH; Craig ME; Januszewski AS; Benitez-Aguirre P; Hing S; Jenkins AJ; Donaghue KC
Diabet Med; 2017 Apr; 34(4):543-550. PubMed ID: 27770590
[TBL] [Abstract][Full Text] [Related]
36. Determinants of Bone Material Strength and Cortical Porosity in Patients with Type 2 Diabetes Mellitus.
Samakkarnthai P; Sfeir JG; Atkinson EJ; Achenbach SJ; Wennberg PW; Dyck PJ; Tweed AJ; Volkman TL; Amin S; Farr JN; Vella A; Drake MT; Khosla S
J Clin Endocrinol Metab; 2020 Oct; 105(10):e3718-29. PubMed ID: 32556277
[TBL] [Abstract][Full Text] [Related]
37. Relationship of skin autofluorescence to severity of retinopathy in type 2 diabetes.
Yasuda M; Shimura M; Kunikata H; Kanazawa H; Yasuda K; Tanaka Y; Konno H; Takahashi M; Kokubun T; Maruyama K; Sato N; Kakizaki M; Sato M; Tsuji I; Miyata T; Nakazawa T
Curr Eye Res; 2015 Mar; 40(3):338-45. PubMed ID: 24871684
[TBL] [Abstract][Full Text] [Related]
38. Smoking and Diabetes Control in Adults With Type 1 and Type 2 Diabetes: A Nationwide Study From the 2018 National Program for Prevention and Control of Diabetes of Iran.
Molla GJ; Ismail-Beigi F; Larijani B; Khaloo P; Moosaie F; Alemi H; Mansournia MA; Ghadimi T; Ghaemi F; Nakhjavani M; Esteghamati A
Can J Diabetes; 2020 Apr; 44(3):246-252. PubMed ID: 31494031
[TBL] [Abstract][Full Text] [Related]
39. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.
Ebeling P; Koivisto VA
Acta Diabetol; 1997 Mar; 34(1):33-8. PubMed ID: 9134055
[TBL] [Abstract][Full Text] [Related]
40. A cross-sectional cohort study with microvascular complications in patients with type 2 diabetes with and without hypothyroidism.
Johnson L; Rayner B
Cardiovasc J Afr; 2020 Jan/Feb 23; 31(1):5-8. PubMed ID: 31469387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
